S

Solve FSHD

5 employees

Solve FSHD fosters innovation and accelerates critical research toward a treatment for facioscapulohumeral muscular dystrophy.

Investor insights

Sectors invested in

Therapeutics3
Health Care2
Biotechnology2
Life Science1
Non Profit1
Medical1

Funding rounds participated in

$3M sweet spot round size

Most of their 3 investments are in rounds between $1M and $3M

Investor type

Family Investment Office

Basic info

Industry

biotechnology research

Sectors

Health Diagnostics
Health Care
Medical

Investments made

V

Vita Therapeutics raised $31M on October 12, 2022

Investors: Riptide Ventures, Cambrian Bio and Solve FSHD

A

Altay Therapeutics raised $3M on September 21, 2022

Investors: Solve FSHD

n

n-Lorem Foundation raised $1M on September 13, 2022

Investors: Solve FSHD

FAQ